PDE-9 inhibitor,
1082743-70-1,
CHEMBL2179094,
PDE-9,
SCHEMBL1716748,
DTXSID10648755,
RVEJWGYZBXCGGM-DNVCBOLYSA-N,
3960AH,
ABP000911,
BDBM50397851,
ZINC66354669,
AKOS030526242,
ZINC139542786,
BCP9001067,
CS-0328,
NCGC00378834-01,
HY-50865,
W-5558,
S14-2771,
1,5-Dihydro-6-[(3S,4S)-4-methyl-1-(phenylmethyl)-3-pyrrolidinyl]-1-(tetrahydro-2H-pyran-4-yl)-4H-pyrazolo[3,4-d]pyrimidin-4-one,
6-((3S,4S)-1-Benzyl-4-methylpyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one,
6-[(3S,4S)-1-Benzyl-4-methylpyrrolidin-3-yl]-1-(oxan-4-yl)-1,2-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one,
6-[(3S,4S)-1-benzyl-4-methylpyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one,
C22H27N5O2,
A3705,
1082743-69-8,
4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-6-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-pyrrolidinyl]-1-(tetrahydro-2H-pyran-4-yl)-, rel-,